A COMMITMENT TO GIVE TO THE WORLD AROUND US
At Lilly, we’re committed to being a leader in corporate responsibility, which includes being an active participant in the communities we serve. We have a robust history of community involvement and believe we can make an impact that extends far beyond the medicines we make. Many of our donations—including those provided through the Eli Lilly and Company Foundation—focus on improving access to medicines and quality health care for millions of people around the globe.
Global Day of Service
Our annual Global Day of Service ranks among the largest single-day volunteer initiatives of any company in the United States. In 2013, about 20,000 employees in nearly 60 global locations volunteered. In seven years, we've totaled more than 725,000 volunteer hours.
Connecting Hearts Abroad
Our corporate volunteer programs harness the power of our employees within their communities. In 2011, we took a new approach to employee volunteerism, building on our long tradition of innovation and caring. Through the Connecting Hearts Abroad program, we send “Lilly Ambassadors” each year on two-week assignments to provide assistance in developing communities in Asia, Africa, and Central and South America, where people lack access to the most basic of resources. The goal is not just to help others, but also to spark employees’ innovative ideas to make Lilly a better company
Enhancing Access to Medicines
One thing we know from experience, the best health solutions come from committed communities and the small choices individuals make every day. Whether it's the community in which you live, or a community of people who are passionate about the same thing, we choose to reach out where we can help make communities stronger and healthier.
The Lilly MDR-TB Partnership offers education, training, and improved care to millions of people around the world who have fallen victim to deadly multidrug-resistant tuberculosis. Among its many efforts, this Partnership delivers indispensable antibiotics to the poor and transfers drug manufacturing know-how to high burden countries.
The Lilly NCD partnership was created to fight the rising burden of non-communicable diseases, specifically diabetes.